EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Natural History of Swiss Infants with Non-SCID T-cell Lymphopenia Detected by Newborn Screening: A Cohort Study

Maarja Soomann, Seraina Prader, Philipp K A Agyeman, Geraldine Blanchard-Rohner, Michael Buettcher, Christian R Kahlert, Nicole Ritz, Aikaterini Theodoropoulou, Jana Pachlopnik Schmid, Johannes Trück

Journal of Clinical Immunology · 2025

DOI: 10.1007/s10875-025-01945-4 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Clinical Immunology, 2025. Verfasst von Maarja Soomann und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology and the Children's Research Center, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland. maarja.s…. Hauptthemen laut MEDLINE: Lymphopenia, T-Lymphocytes. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Zurich.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Newborn screening (NBS) by quantification of T-cell receptor excision circles (TREC) identifies a considerable number of infants with T-cell lymphopenia (TCL) other than severe combined immunodeficiency (SCID). While some of these children have well-defined inborn errors of immunity (IEI), many lack a clear genetic diagnosis, complicating their management and causing prognostic uncertainty.

Objective

To characterize the natural history of non-SCID TCL detected through NBS in Swiss infants between 2019 and 2023.

Methods

Clinical, genetic and laboratory data from all non-SCID TCL cases were extracted from the national NBS registry and analyzed.

Results

Out of 435 985 screened infants, 42 patients were identified with non-SCID, non-congenital athymia TCL, without an obvious secondary cause. A clear genetic diagnosis of IEI was established in 20 (48%) patients. Infants with confirmed IEI had significantly lower total T-cell, CD4 + T-cell and recent thymic emigrant (RTE) counts on initial lymphocyte phenotyping. In contrast, those with an unclear genetic diagnosis despite full investigations demonstrated faster normalization of total T-cell counts (hazard ratio 5.2, 95% CI 1.9 to 14.5, p = 0.001). All infants with initial CD4 + T-cell < 0.3 × 10 9 /L showed minimal recovery of T-cell counts and remained on long-term prophylactic measures. All infants with an unclear genetic diagnosis despite investigations were able to discontinue prophylaxis at median age 6 months without experiencing opportunistic or severe infections.

Conclusion

Infants with non-SCID TCL identified by NBS represent a heterogenous group, ranging from severe, persistent TCL to mild, transient lymphopenia. Management should be tailored based on individual immunological and genetic profiles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LymphopeniaT-LymphocytesHumansNeonatal ScreeningInfant, NewbornMaleSwitzerlandFemaleInfantSevere Combined ImmunodeficiencyCohort StudiesReceptors, Antigen, T-Cell

Stichwörter der Autor:innen

Combined immunodeficiencyGeneticsIdiopathic T-cell lymphopeniaInborn errors of immunityNewborn screeningT-cell deficiencyT-cell lymphopeniaTCLTREC

Substanzen

Receptors, Antigen, T-Cell

Autor:innen und Institutionen

  • Division of Immunology and the Children's Research Center, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland. maarja.soomann@kispi.uzh.ch.
  • Division of Immunology and the Children's Research Center, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Division of Pediatric Infectious Disease, Department of Pediatrics, lnselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Unit of Immunology, Vaccinology and Rheumatology, Division of General Pediatrics, Department of Pediatrics, Gynecology and Obstetrics, Geneva University Hospitals, Geneva, Switzerland.
  • Pediatric Infectious Diseases, Department of Pediatrics, Children's Hospital of Central Switzerland (KidZ), Lucerne Cantonal Hospital, Lucerne, Switzerland.
  • Pediatric Pharmacology and Pharmacometrics Research Center, University Children's Hospital Basel (UKBB), Basel, Switzerland.

Förderung

  • University of Zurich

Zitieren

APA

Soomann, M., Prader, S., Agyeman, P. K. A., Blanchard-Rohner, G., Buettcher, M., Kahlert, C. R., Ritz, N., Theodoropoulou, A., Pachlopnik Schmid, J., & Trück, J. (2025). Natural History of Swiss Infants with Non-SCID T-cell Lymphopenia Detected by Newborn Screening: A Cohort Study. Journal of Clinical Immunology. https://doi.org/10.1007/s10875-025-01945-4

Vancouver

Soomann M, Prader S, Agyeman PKA, Blanchard-Rohner G, Buettcher M, Kahlert CR, et al. Natural History of Swiss Infants with Non-SCID T-cell Lymphopenia Detected by Newborn Screening: A Cohort Study. Journal of Clinical Immunology. 2025. doi:10.1007/s10875-025-01945-4

BibTeX
@article{Soomann2025,
  author = {Soomann, Maarja and Prader, Seraina and Agyeman, Philipp K A and Blanchard-Rohner, Geraldine and Buettcher, Michael and Kahlert, Christian R and Ritz, Nicole and Theodoropoulou, Aikaterini and Pachlopnik Schmid, Jana and Trück, Johannes},
  title = {Natural History of Swiss Infants with Non-SCID T-cell Lymphopenia Detected by Newborn Screening: A Cohort Study},
  journal = {Journal of Clinical Immunology},
  year = {2025},
  doi = {10.1007/s10875-025-01945-4}
}
Kostenlos starten →